# AEterna Zentaris clinical trials: 34 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 34 trials with AEterna Zentaris as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by AEterna Zentaris: 34 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/aeterna-zentaris

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 34
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 34, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| March 8, 2021 | NCT04786873 | A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is | AEterna Zentaris | Phase 3 | Completed | Growth Hormone Deficiency | 101 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04786873) |
| September 24, 2015 | NCT02558829 | Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency | AEterna Zentaris | Phase 3 | Completed | Growth Hormone Deficiency With Pituitary Anomalies | 157 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02558829) |
| January 14, 2013 | NCT01767155 | Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer | AEterna Zentaris | Phase 3 | Completed | Endometrial Cancer | 511 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01767155) |
| October 2, 2012 | NCT01698281 | Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer | AEterna Zentaris | Phase 2 | Terminated | Breast Cancer | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01698281) |
| November 4, 2010 | NCT01234519 | A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy | AEterna Zentaris | Phase 1/2 | Terminated | Urothelial Carcinoma | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01234519) |
| October 20, 2010 | NCT01224730 | A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies | AEterna Zentaris | Phase 1 | Completed | Cancer | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01224730) |
| April 1, 2010 | NCT01097018 | Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer | AEterna Zentaris | Phase 3 | Completed | Colorectal Cancer | 468 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01097018) |
| January 13, 2010 | NCT01048580 | Study of Perifosine + Capecitabine for Colon Cancer Patients | AEterna Zentaris | Phase 1 | Completed | Colon Cancer | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01048580) |
| October 27, 2009 | NCT01002248 | Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients | AEterna Zentaris | Phase 3 | Terminated | Multiple Myeloma | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01002248) |
| February 19, 2009 | NCT00847366 | Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma | AEterna Zentaris | Not applicable | Completed | Non Small Cell Lung Cancer, Solid Tumors, Metastatic Breast Cancer, Sarcomas | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00847366) |
| May 1, 2008 | NCT00670306 | Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) | AEterna Zentaris | Phase 3 | Completed | Benign Prostatic Hypertrophy | 528 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00670306) |
| April 22, 2008 | NCT00663858 | Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) | AEterna Zentaris | Phase 3 | Completed | Benign Prostatic Hypertrophy | 420 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00663858) |
| December 7, 2007 | NCT00569257 | Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors | AEterna Zentaris | Phase 2 | Completed | Ovarian Cancer, Endometrial Cancer | 85 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00569257) |
| July 11, 2007 | NCT00498966 | Ph II Study of Perifosine for Patients With Carcinoma of the Kidney | AEterna Zentaris | Phase 2 | Completed | Kidney Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00498966) |
| April 3, 2007 | NCT00455559 | Ph II Study of Perifosine Plus Gleevec for Patients With GIST | AEterna Zentaris | Phase 2 | Completed | Gastrointestinal Stromal Tumors | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00455559) |
| March 19, 2007 | NCT00449150 | Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) | AEterna Zentaris | Phase 3 | Terminated | Benign Prostatic Hypertrophy | 667 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00449150) |
| March 19, 2007 | NCT00448747 | Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test. | AEterna Zentaris | Phase 3 | Completed | Diagnosis of Adult Growth Hormone Deficiency (AGDH) | 101 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00448747) |
| March 19, 2007 | NCT00448721 | A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer | AEterna Zentaris | Phase 2 | Completed | Renal Cell Carcinoma | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00448721) |
| December 22, 2006 | NCT00415064 | Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma | AEterna Zentaris | Phase 1 | Completed | Multiple Myeloma | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00415064) |
| November 20, 2006 | NCT00401388 | A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas | AEterna Zentaris | Phase 2 | Completed | Chondrosarcomas, Alveolar Soft Part Sarcomas, Extra Skeletal Myxoid Chondrosarcomas | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00401388) |
| November 17, 2006 | NCT00401011 | Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients | AEterna Zentaris | Phase 1/2 | Completed | Multiple Myeloma, Multiple Myeloma in Relapse | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00401011) |
| November 15, 2006 | NCT00399789 | A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer | AEterna Zentaris | Phase 1/2 | Completed | Non Small Cell Lung Cancer | 121 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00399789) |
| November 14, 2006 | NCT00399152 | Perifosine + Sunitinib Malate for Patients With Advanced Cancers | AEterna Zentaris | Phase 1 | Completed | Renal Cancer, GIST | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00399152) |
| November 14, 2006 | NCT00399126 | Phase I Trial of Paclitaxel With Perifosine | AEterna Zentaris | Phase 1 | Completed | Neoplasms | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00399126) |
| November 14, 2006 | NCT00399087 | Phase I Trial of Docetaxel With Perifosine | AEterna Zentaris | Phase 1 | Completed | Neoplasms | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00399087) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 8 |
| Phase 1/2 | 3 |
| Phase 2 | 12 |
| Phase 3 | 10 |
| Not applicable | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 30 |
| Terminated | 4 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Neoplasms | 6 |
| Multiple Myeloma | 5 |
| Kidney Neoplasms | 4 |
| Prostatic Hyperplasia | 3 |
| Carcinoma, Renal Cell | 2 |
| Breast Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Colonic Neoplasms | 2 |
| Dwarfism, Pituitary | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Ovarian Neoplasms | 1 |
| Neoplasms, Plasma Cell | 1 |
| Leukemia | 1 |
| Recurrence | 1 |
| Sarcoma | 1 |
| Growth Hormone Deficiency With Pituitary Anomalies | 1 |
| Carcinoma, Transitional Cell | 1 |
| Ureteral Neoplasms | 1 |
| Urinary Bladder Neoplasms | 1 |
| Chondrosarcoma | 1 |
| Sarcoma, Alveolar Soft Part | 1 |
| Colorectal Neoplasms | 1 |
| Liver Neoplasms | 1 |
| Lymphoma | 1 |
| Gastrointestinal Stromal Tumors | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Landscaping companies in the United States](https://specstream.ai/data/businesses/landscaping-companies/united-states)
- [Investment management firms in the United States](https://specstream.ai/data/businesses/investment-management-firms/united-states)
- [Hydraulic repair companies in the United States](https://specstream.ai/data/businesses/hydraulic-repair-companies/united-states)
- [High schools in the United States](https://specstream.ai/data/businesses/high-schools/united-states)
- [Geological services in the United States](https://specstream.ai/data/businesses/geological-services/united-states)
- [Flooring contractors in the United States](https://specstream.ai/data/businesses/flooring-contractors/united-states)
